Performance of diagnostic or therapeutic endoscopic procedures in inflammatory bowel disease (IBD) patients can be challenging during a viral pandemic; the main concerns being the safety and protection of patients and health care providers (HCP). The aim of this study is to identify endoscopic practice patterns and outcomes of IBD and coronavirus disease 19 (COVID-19) with a worldwide survey of HCP.

The 20-item survey questionnaire was sent to physician members of the American Society for Gastrointestinal Endoscopy Special Interest Group in Interventional IBD, Chinese IBD Society Endoscopy Interest Group, and the China Crohn's and Colitis Foundation. The data of the survey was collected and analyzed.

Inclusion Criteria:

1. Doctors who are involved in the endoscopic treatment of IBD patients;
2. The endoscopist reads and signs an informed consent online. -

Exclusion Criteria:

1. Doctors who are not involved in the endoscopic treatment of IBD patients
2. Doctors who need the help of an agent, a witness, or someone else who can not complete the questionnaire independently.
3. Other conditions that the researchers considered unsuitable for inclusion or influenced the participants'ability to complete the study.-

The content of survey included: The number of procedures, the indication of endoscopy, the number of patients with IBD diagnosed Covid-19, and the influence of the epidemic situation on the diagnosis and treatment of IBD.

The result of questionnaire can be shared

now is available

All the doctors